We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+12.31%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$33.4B
AUM Growth
+$2.35B
Cap. Flow
-$652M
Cap. Flow %
-1.96%
Top 10 Hldgs %
25.9%
Holding
1,133
New
72
Increased
394
Reduced
425
Closed
76

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$242M
2
AMZN icon
Amazon
AMZN
+$69.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$67M
4
UBS icon
UBS Group
UBS
+$59.2M
5
LW icon
Lamb Weston
LW
+$58.5M

Top Sells

Rank Stock Value
1
AXNX
Axonics, Inc. Common Stock
AXNX
+$105M
2
AAPL icon
Apple
AAPL
+$87.1M
3
APTV icon
Aptiv
APTV
+$80.3M
4
TSCO icon
Tractor Supply
TSCO
+$80M
5
DE icon
Deere & Co
DE
+$78.5M

Sector Composition

Rank Sector Weight
1 Technology 35.56%
2 Healthcare 16.52%
3 Consumer Discretionary 11.68%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDN icon
426
Radian Group
RDN
$4.68B
$8.52M 0.03%
254,422
+63,322
+33% +$1.86M
SNA icon
427
Snap-on
SNA
$19.4B
$8.48M 0.03%
28,643
-89,561
-76% -$25.4M
WHR icon
428
Whirlpool
WHR
$2.15B
$8.47M 0.03%
70,764
-7,644
-10% -$852K
TNET icon
429
TriNet
TNET
$3.18B
$8.45M 0.03%
63,795
-21,834
-25% -$2.65M
CYTK icon
430
Cytokinetics
CYTK
$9.64B
$8.42M 0.03%
120,111
+34
+0% +$2.63K
KMI icon
431
Kinder Morgan
KMI
$68.5B
$8.38M 0.03%
456,912
+123,631
+37% +$2.16M
MUSA icon
432
Murphy USA
MUSA
$9.67B
$8.38M 0.03%
19,987
-36
-0.2% -$14.1K
HSY icon
433
Hershey
HSY
$34.2B
$8.37M 0.03%
43,013
+9,235
+27% +$1.78M
ONC
434
BeOne Medicines Ltd
ONC
$39.2B
$8.36M 0.03%
53,467
-1,667
-3% -$268K
SJM icon
435
J.M. Smucker
SJM
$13B
$8.36M 0.03%
66,425
+5,179
+8% +$656K
BRO icon
436
Brown & Brown
BRO
$22.5B
$8.33M 0.03%
95,200
-29,283
-24% -$2.35M
LFT
437
Lument Finance Trust
LFT
$34.1M
$8.32M 0.02%
334,078
M icon
438
Macy's
M
$5.77B
$8.21M 0.02%
410,724
-19,370
-5% -$374K
XENE icon
439
Xenon Pharmaceuticals
XENE
$5.45B
$8.09M 0.02%
187,872
+51
+0% +$2.35K
ELF icon
440
e.l.f. Beauty
ELF
$5.63B
$8M 0.02%
40,789
-17,232
-30% -$3.06M
VIPS icon
441
Vipshop
VIPS
$5.75B
$7.95M 0.02%
480,442
+74,668
+18% +$1.26M
DYN icon
442
Dyne Therapeutics
DYN
$3.34B
$7.91M 0.02%
278,566
-271,758
-49% -$6.15M
INSM icon
443
Insmed
INSM
$26.2B
$7.83M 0.02%
288,599
-63,447
-18% -$1.78M
AGIO icon
444
Agios Pharmaceuticals
AGIO
$1.96B
$7.76M 0.02%
265,373
+74
+0% +$1.98K
TMDX icon
445
Transmedics
TMDX
$3.05B
$7.76M 0.02%
104,893
-11,708
-10% -$965K
STNE icon
446
StoneCo
STNE
$2.23B
$7.74M 0.02%
465,899
+54,763
+13% +$939K
R icon
447
Ryder
R
$9.25B
$7.71M 0.02%
64,116
-2,784
-4% -$317K
CUBE icon
448
CubeSmart
CUBE
$8.99B
$7.68M 0.02%
169,936
+11,920
+8% +$528K
BXP icon
449
Boston Properties
BXP
$10.2B
$7.68M 0.02%
117,648
-65,417
-36% -$4.33M
SRPT icon
450
Sarepta Therapeutics
SRPT
$2.19B
$7.62M 0.02%
58,894
+15
+0% +$1.84K

Similar funds

Axa's Q1 2024 Portfolio in Review

As of Q1 2024, Axa held 1,133 positions worth $33.4B, up 7.6% from $31B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Axa's Q1 2024 filing shows 72 new, 394 increased, 425 reduced and 76 closed positions. Its largest new stake was Lamb Weston: 561,708 shares worth $59.8M. The largest sale was Axonics, Inc. Common Stock, an estimated $105M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q1 2024 buy was Lamb Weston: 561,708 shares worth $59.8M.
  • Axa added most to Meta Platforms (Facebook) in Q1 2024, an estimated $242M increase.
  • Axa's biggest Q1 2024 reduction was Axonics, Inc. Common Stock, cutting an estimated $105M.
  • Axa fully exited Archer Daniels Midland in Q1 2024, selling an estimated $53.4M.
  • Axa's ten largest holdings make up 26% of its $33.4B portfolio in Q1 2024.
  • Axa opened 72 new positions and closed 76 in Q1 2024.
  • Axa's portfolio value rose 7.6% quarter-over-quarter to $33.4B.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.